Rocío Gallego‐Durán
Consejo Superior de Investigaciones Científicas · 207 works · 5,678 citations · h-index 35
Top works
- Mapping the human genetic architecture of COVID-19
- Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis
- 18 DETERMINATION OF FIBROSIS STAGE AND STEATOHEPATITIS IN PATIENTS WITH NAFLD BY OPTICAL ANALYSIS OF MAGNETIC RESONANCE IMAGES COMBINED WITH ARTIFICIAL NEURAL NETWORKS (FIBROMRi AND NASHMRi)
- Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease
- Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
- Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
- The effects of metabolic status on non‐alcoholic fatty liver disease‐related outcomes, beyond the presence of obesity
- Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease
- Development and Validation of Hepamet Fibrosis Scoring System–A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis
- An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)
- MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
- miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis
- Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease
- Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis.
- Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica
- Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH
- From “Burnt-Out” to “Burning-Out”: Capturing Liver Fat Loss in Patients With Advanced Metabolic Dysfunction–Associated Steatotic Liver Disease From a Dynamic Perspective
- Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD)
- Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease
- A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3′UTR